Back
 ABCR  Vol.5 No.2 , April 2016
Is Postmastectomy Radiation Therapy Indicated in Patients with Close or Positive Margins?
Abstract: Background: The indications for Post Mastectomy Radiation Therapy (PMRT) for positive or close margins are unclear. We examined the indications for PMRT in mastectomy patients with close or positive margins and determined patterns for relapse and survival. Methods: The pathology reports of 610 patients treated with a mastectomy from 1999-2012 were reviewed. Of these, 72 patients had a positive or <2 mm margin. Demographic, tumor characteristics, treatments and survival were compared between women treated with and without PMRT. Results: The mean follow up was 4.1 years. Patients who received PMRT were younger (p = 0.03) and more likely to receive chemotherapy (p = 0.03). Patients with lymphovascular invasion (LVI) were more likely to undergo PMRT (p = 0.02). Seven patients who did not receive PMRT recurred. There was no correlation with locoregional failure. The disease free survival was better in the PMRT group (p = 0.03), but the overall survival was the same. Conclusion: We found that women with a close or positive margin who were younger, had LVI, and who received chemotherapy received PMRT. The disease free survival was better in the PMRT cohort, but the overall survival was similar. Long-term follow up of patients is warranted to see if PMRT offers a survival advantage.
Cite this paper: Bryan, M. , D’Agostino, R. , Brown, D. and Howard-McNatt, M. (2016) Is Postmastectomy Radiation Therapy Indicated in Patients with Close or Positive Margins?. Advances in Breast Cancer Research, 5, 66-73. doi: 10.4236/abcr.2016.52007.
References

[1]   Overgaard, M., Hansen, P.S., Overgaard, J., Rose, C., Andersson, M., Bach, F., et al. (1997) Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer who Receive Adjuvant Chemotherapy: Danish Breast Cancer Cooperative Group 82b Trial. The New England Journal of Medicine, 337, 949-955.
http://dx.doi.org/10.1056/NEJM199710023371401

[2]   Ragaz, J., Jacjson, S.M., Le, N., Plenderleith, I.H., Spinelli, J.J., Basco, V.E., et al. (1997) Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer. The New England Journal of Medicine, 337, 956-962.
http://dx.doi.org/10.1056/NEJM199710023371402

[3]   Recht, A., Edge, S.B., Solin, L.J., Robinson, D.S., Estabrook, A., Fine, R.E., et al. (2001) Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology. Journal of Clinical Oncology, 19, 1539-1569.

[4]   Taylor, M.E., Haffty, B.G., Rabinovitch, R., Arthur, D.W., Halberg, F.W., Strom, E.A., et al. (2009) ACR Appropriateness Criteria on Postmastectomy Radiotherapy. Expert Panel on Radiation Oncology-Breast. International Journal of Radiation Oncology, Biology, Physics, 73, 997-1002.
http://dx.doi.org/10.1016/j.ijrobp.2008.10.080

[5]   Truong, P.T., Olivotto, I.A., Whelan, T.J. and Levine, M. (2004) Clinical Practice Guidelines for the Care and Treatment of Breast Cancer: 16. Locoregional Post-Mastectomy Radiotherapy. Canadian Medical Association Journal, 170, 1263-1273.
http://dx.doi.org/10.1503/cmaj.1031000

[6]   Overgaard, M., Jensen, M.B., Overgaard, J., Hansen, P.S., Rose, C., Andersson, M., et al. (1999) Postoperative Radiotherapy in High-Risk Postmenopausal Breast-Cancer Patients Given Adjuvant Tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c Randomized Trial. Lancet, 353, 1641-1648.
http://dx.doi.org/10.1016/S0140-6736(98)09201-0

[7]   EBCTCG Early Breast Cancer Trialists’ Collaborative Group (2014) Effect of Radiotherapy after Mastectomy and Axillary Surgery on 10-Year Recurrence and 20-Year Breast Cancer Mortality: Meta-Analysis of Individual Patient Data for 8135 Women in 22 Randomized Trials. Lancet, 383, 2127-2135.
http://dx.doi.org/10.1016/S0140-6736(14)60488-8

[8]   Hastings, J., Iganej, S., Huang, C., Huang, R. and Slezak, J. (2014) Risk Factors for Locoregional Recurrence after Mastectomy in Stage T1 N0 Breast Cancer. American Journal of Clinical Oncology, 37, 486-491.
http://dx.doi.org/10.1097/COC.0b013e31827e54c2

[9]   Rashtian, A., Iganej, S., Amy Liu, I.L. and Natarajan, S. (2008) Close or Positive Margins after Mastectomy for DCIS: Pattern of Relapse and Potential Indications for Radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 72, 1016-1020.
http://dx.doi.org/10.1016/j.ijrobp.2008.06.1954

[10]   Freedman, G.M., Fowble, B.L., Hanlon, A.L., Myint, M.A., Hoffman, J.P., Sigurdson, E.R., et al. (1998) A Close or Positive Margin after Mastectomy Is Not an Indication for Chest Wall Irradiation Except in Women Aged Fifty or Younger. International Journal of Radiation Oncology, Biology, Physics, 41, 599-605.
http://dx.doi.org/10.1016/S0360-3016(98)00103-5

[11]   Truong, P.T., Olivotto, I.A., Speers, C.H., Way, E.S., Berthelet, E. and Kader, H.A. (2004) A Positive Margin Is Not Always an Indication for Radiotherapy after Mastectomy in Early Breast Cancer. International Journal of Radiation Oncology, Biology, Physics, 58, 797-804.
http://dx.doi.org/10.1016/S0360-3016(03)01626-2

[12]   FitzSullivan, E., Lari, S.A., Smith, B., Caudle, A.S., Krishnamurthy, S., Lucci, A., et al. (2013) Incidence and Consequence of Close Margins in Patients with Ductal Carcinoma-In Situ Treated with Mastectomy: Is Further Therapy Warranted? Annals of Surgical Oncology, 20, 4103-4112.
http://dx.doi.org/10.1245/s10434-013-3194-0

[13]   Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of Chemotherapy and Hormonal Therapy for Early Breast Cancer on Recurrence and 15-Year Survival: An Overview of the Randomised Trials. Lancet, 36, 1687-1717.

 
 
Top